Short Communications
Vol. 30 No. 2 (2015)
https://doi.org/10.4081/mm.2015.4674

Aeromonas spp.: an emerging pathogen?

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 18 August 2014
Accepted: 29 May 2015
Published: 18 December 2015
2818
Views
962
Downloads
457
HTML
Aeromonas spp., diarrhea, emerging waterborne gastroenteritis

Authors

Andrea Bartolini
andbarto@libero.it
Operative Unit of Microbioly and Virology, Hospital of Padua; Department of Molecular Medicine, University of Padua, Italy.
Giulia Zorzi
Operative Unit of Microbioly and Virology, Hospital of Padua; Department of Molecular Medicine, University of Padua, Italy.
Elena Castellani
Operative Unit of Microbioly and Virology, Hospital of Padua; Department of Molecular Medicine, University of Padua, Italy.
Valeria Besutti
Operative Unit of Microbioly and Virology, Hospital of Padua, Italy.
The aim of this study is to identify and monitor the presence of Aeromonas spp. strains in stool cultures. We analyzed 5564 stool cultures from September 2012 to August 2013. Sixty-three patients were positive for Aeromonas spp. The most frequent symptoms were: diarrhea (46.0%) and abdominal pain (12.7%). Pediatric subjects were 28. Samples’ microscopic examination showed leukocytes in 38.1% of cases. It is still controversial whether Aeromonas are responsible for human gastroenteritis, but their presence in faecies of symptomatic patients supports their etiologic role. We propose search for toxins by polymerase chain reaction to identify strains that require an antibiotic therapy.

Downloads

Download data is not yet available.

How to Cite



Aeromonas spp.: an emerging pathogen? (2015). Microbiologia Medica, 30(2). https://doi.org/10.4081/mm.2015.4674

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.